Organic Chemistry TRIZ Cases

Specific heterocyclic and heteroaryl groups modify HIV protease inhibitors to reduce hepatic metabolism and support less frequent dosing.

Polymorphism can disrupt drug stability, solubility, and bioavailability; XRPD, DSC, TGA, and controlled preparation conditions help define reproducible forms.

Low electron mobility and poor thermal stability limit organic devices; this compound combines a nitrogen heterocycle with an adamantane-fluorene group.

Specific bicarbazole cores and added carbazole groups optimize hole transport and emission for greater OLED efficiency and longer device life.

Ester, thioester, and hydrazide moieties help SMO antagonists degrade in blood, limiting systemic exposure while supporting topical Hedgehog-pathway treatment.

Water-soluble multifunctional crosslinkers replace VOC-based solvents in UV-cured lubricious coatings for plastic medical devices.

The negative-type resin uses functionalized binder chemistry to improve pigment compatibility, pattern straightness, and OLED luminance without a polarizing plate.

Aromatic nitrogen insertion and substitution tuning address poor solubility and high lipophilicity while preserving potent, selective GPR52 activation.

Small-molecule NPRA agonists address the short half-lives of ANP and BNP by sustaining receptor activation for cardiometabolic disease treatment.

Liquid nicotine absorbs into porous cellulosic fibers, stabilizing it for molded oral products with adjustable release rates.

Repeated apheresis offers only temporary Lp(a) reduction; pyrrolidine compounds provide a pharmaceutical approach to lowering this cardiovascular risk factor.

Compounds targeting KIF18A ATPase activity induce mitotic arrest and apoptosis, addressing uncontrolled proliferation in cancer cells.

Thermally flowable organic films fill and planarize complex substrates while balancing fine-pattern resolution, etch resistance, and adhesion.

Limited fluoropolymer varieties and specialized reactors are addressed with a PEG-grafted semi-fluorinated copolymer that forms micelles at low concentration.

YAP1/TAZ-TEAD inhibition by these acrylamide-substituted indane compounds offers a small-molecule route to address cancer drug resistance.

Hydroxylamine buildup limits aromatic nitro reduction; nitroreductase and a disproportionation agent drive over 90% amine yield at ambient conditions.

Selective mutant IDH inhibition blocks α-KG-to-D-2-HG conversion while preserving normal TCA cycle function.

Controlled E/Z macrocycle ratios strengthen powdery, creamy musk notes while reducing metallic character in perfuming compositions.

Oxidizing HMF with molecular oxygen and a reusable ruthenium catalyst enables high-yield FDCA production, followed by nanofiltration for purity.

Specific polycyclic compounds in transport and emission layers improve charge and heat resistance for longer element service life.

Apple juice catalyzes N-substituted pyrrole formation from amines and hexadione under mild aqueous conditions, avoiding hazardous reagents and organic solvents.

Limited options for KRAS-mutated cancers motivate naphthyridine compounds that inhibit KRAS activity.

Specific heteroaryl host structures address the OLED trade-off between high driving voltage, luminous efficiency, and lifespan.

FL118 complexes combine cyclodextrins, human proteins or fragments, and salts to degrade DDX5, UbE2T, and USP2a linked to drug resistance.

A hypervalent iodine and carboxylic acid resist supports high-sensitivity EUV micropatterning with improved resolution and lower LWR.

Iodine-enhanced EUV absorption and localized acid generation help the resist balance sensitivity with LWR, CDU, solvent solubility, and etch resistance.

CRBN-recruiting PROTACs link NVS-PAK1-1 to targeted ubiquitination, addressing weak PAK1 selectivity, stability, and micromolar potency.

An indolocarbazole compound helps photoelectric imaging devices generate and move charge for higher sensitivity and resolution.

A Formula (I) electron-transport compound tunes LUMO level and dipole moment to balance OLED lifetime, efficiency, and driving voltage.

Conventional deuteration can demand costly high-temperature, high-pressure synthesis; this approach uses a transition-metal catalyst and heavy water under mild conditions.

Recovering Saflufenacil from mother liquor uses pH-driven salt formation, aqueous extraction, and organic back-extraction to limit degradation.

Small molecular changes make aroma prediction difficult; norbornane derivatives provide toasted coconut and nutty notes for fragrance and flavor products.

Small-molecule inhibitors target IL-4 signaling to reduce inflammation across autoimmune, allergic, arthritis, and cancer-related conditions.

Replacing DMSO with an alcoholic solvent and phase-transfer catalyst addresses thermal decomposition, waste, and low yields.

A hypervalent iodine compound exchanges ligands with a carboxy polymer, improving resist sensitivity and resolution for precise EUV micropatterns.

A magnesium-based Grignard route forms δ-tocotrienol at elevated temperatures, avoiding toxic reagents and difficult cryogenic processing.

The case targets KRAS-mutant signaling with SOS1 inhibitors designed for oral absorption, metabolic stability, and low CYP inhibition.

Photosensitized polymer blends support precise OTFT patterning while protecting organic semiconductor layers from oxygen plasma and aggressive solvents.

Defined ionizable lipid structures help nanoparticles encapsulate mRNA and target tissues while reducing multi-lipid formulation complexity.

Replacing carbon monoxide and hydrazine with metal-catalyzed conditions simplifies intermediate synthesis for safer industrial scale-up.

Fluorinated building blocks address limited selectivity and scale-up in 1-position N-substitution while enabling 5-position trifluoromethyl pyridones.

Carboxyl anions and tertiary sulfonium groups keep the polymer water-soluble while stabilizing proteins at low concentration and scavenging reactive oxygen species.

Heteroaryl aminopropanol compounds inhibit LTA4H, elevate lipoxin A4 biosynthesis, and promote resolution of chronic inflammation.

High-pressure hydrogenation and extra purification affect product quality; this route combines batch and fixed-bed hydrogenation for selective diamine synthesis.

YAP-TEAD interaction inhibition uses formula (Ia) compounds to address Hippo pathway dysregulation in cancer and chronic pain.

A PROTAC molecule combines selective IRAK4 kinase inhibition with ubiquitin-proteasome degradation to address resistance and limited activity.

A compound emitting layer pairs a first material with a fluorescent dopant to address efficiency roll-off at high current density.

Specific nitrile compounds help keep acrylonitrile stable in iron or iron-alloy containers, limiting polymerization during storage.

Quinazoline derivatives use a halogen-containing reactive group to form covalent cysteine bonds, enabling durable tyrosine kinase inhibition.

An organic blue-absorbing film selectively captures blue light in small pixels, improving sensitivity and reducing inter-pixel crosstalk.

Ammonium carboxylate ionic bonds enable water-soluble removal of temporary supports while maintaining mechanical strength.

Formula I salts with acid-labile groups resolve resolution limits in conventional resist compositions by enabling precise pattern definition.

A visible light activated ink uses photochromic compounds to produce a color change under ordinary illumination.

Tricyclic compounds inhibit delta-5-desaturase to restrict arachidonic acid formation.

Formula I pendant amines inhibit leukotriene A4 hydrolase to reduce inflammatory mediator production.

Pentafluorosulfanyl-substituted amide derivatives inhibit indoleamine 2,3-dioxygenase activity with high potency.

Heterocyclic derivatives inhibit Factor XIIa activity to treat angioedema while minimizing bleeding risks.

A fluorene derivative targets multiple viral proteins to inhibit hepatitis C virus replication.

Specific imidazole compounds adsorb onto microparticles to prevent aggregation during storage while promoting curing of thermosetting base materials.

Tuning the LUMO energy level difference between N-type and P-type materials via substituent groups reduces turn-on voltage in light-emitting devices.

A photoresist resin containing sultone rings and acid-labile groups enables precise pattern formation through controlled alkali solubility changes.

Specific amine structures optimize HOMO energy levels to reduce driving voltage and extend device lifespan in organic light-emitting displays.

An organic light-emitting device uses an oligomer-polymer composite in the light-emitting layer to resolve lifetime limits from molecular weight control issues.

Phenazine compounds replace toxic inorganic materials to eliminate environmental risks while maintaining electrochemical stability.

Arylamide derivatives target NaV1.3 and NaV1.7 channels, resolving the selectivity trade-off that causes side effects with conventional blockers.

Structural optimization of heterocyclic ligands resolves the contradiction between low plasma stability and therapeutic effectiveness in PAR1 modulation.

Cycloalkane moieties fused to polycyclic aromatic hydrocarbon cores reduce intermolecular interactions through steric protection.

A glycoluril derivative with an acrylate group forms a negative-type photosensitive composition that creates clean-edged holes in organic thin films.

A one-pot process synthesizes hexahydroisoquinolines directly from amides using sequential cyclization and reduction steps.

Combining CXCR4 antagonists, STAT3 activators, and nitric oxide agents bridges nerve gaps over 3 cm without exogenous cells.

Replaces unstable ethyl malonyl chloride with a stable dioxolane intermediate to achieve high purity and yield.

Oxadiazole-substituted benzimidazole derivatives inhibit DGAT1 to reduce triglyceride synthesis, addressing obesity and insulin resistance.

Gas-phase formaldehyde trimerization over solid acid catalysts eliminates energy-intensive distillation and reduces side products.

Non-halogenated deoxybenzoin polymers resolve toxicity trade-offs by forming insulating char layers that suppress combustion without mechanical property loss.

Pharmaceutically acceptable Akt inhibitor salts prevent precipitation at specific pH levels, ensuring stable delivery and therapeutic efficacy.

Compounds bind the palmitate-binding pocket to disrupt TEAD-YAP interaction, addressing challenges in targeting oncogenic transcription factors.

N,N-diethyl-N′-phenyl piperazine derivatives stabilize alpha7 nicotinic acetylcholine receptor desensitized states.

Rhenium and potassium promoters stabilize silver catalysts, resolving selectivity versus deactivation trade-offs in olefin epoxidation.

Indenobenzo[k]fluoranthene derivatives emit blue light through a rigid planar skeleton that suppresses quantum yield reduction.

Amine compounds suppress exciton energy diffusion in the hole transport region, improving luminous efficiency and extending device lifetime.

Lipase-catalyzed amidation of unprotected amino acids overcomes low solubility in organic solvents, achieving high atom economy and minimal waste.

A chemically amplified positive resist composition utilizes a benzotriazole compound to form high-resolution patterns on copper substrates.

Perfluoropyridine derived aromatic monomers replace toxic cyanate ester resins to eliminate hydrogen cyanide generation while maintaining high char yields.

Formula 1 spiroxanthene compounds reduce operational voltage and enhance thermal stability in organic light emitting diodes.

Continuous flow processing isolates pure meropenem trihydrate, minimizing residence time to prevent decomposition and reduce impurity content.

A compound featuring a dibenzofuranyl group bonded via a p-phenylene group to a central nitrogen atom improves electron transport in organic electroluminescent devices.

Small molecule compounds mimic hematopoietic growth factor receptors to stimulate blood cell production, bypassing complex recombinant protein manufacturing.

Sulfide precipitation removes heavy metal contaminants from ionic liquids, restoring scrubbing efficiency without complex regeneration steps.

Substituent tuning of the phenanthroline core lowers injection barriers and blocks holes, reducing driving voltage while maintaining thermal stability.

Novel 15-PGDH inhibitor compounds featuring specific heterocyclic structures to enhance medicinal efficacy.

Optimized supercritical fluid chromatography with ethanol modifiers achieves 99% purity, overcoming isomer separation limits in commercial production.

Eliminating solvents and silica gel chromatography from NS-304 synthesis resolves purification difficulties while boosting yield.

Modified salvianic acid derivatives cross the cardiocerebral barrier, increasing cerebral microcirculatory blood flow and reducing myocardial infarction areas.

Segmented cation-anion structures lower surface tension to resolve the thermal stability versus monolayer thickness trade-off in nanoscale devices.

Click chemistry conjugates mechanophores to substrates, enabling force detection at low strains while avoiding placement precision issues.